Refine your interests »
On Tuesday, May 23, 2023, Janssen and Amgen settled their case regarding Amgen’s proposed biosimilar to Stelara in Delaware district court. Stelara, also known as ustekinumab, is an anti-IL-12/IL-23 antibody drug used to...more